The home spirometer market size was valued at USD 1.17 billion in 2023 and is expected to hit USD 1.62 billion by 2032, growing at a CAGR of 3.70% from 2023 to 2032.
Key Takeaways
- North America contributed more than 34% of revenue share in 2022.
- Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By type, the table-top segment has held the largest market share of 65% in 2022.
- By type, the hand-held segment is anticipated to grow at a remarkable CAGR of 4.2% between 2023 and 2032.
- By technology, the flow measurement segment generated over 61% of revenue share in 2022.
- By technology, the volume measurement segment is expected to expand at the fastest CAGR over the projected period.
- By application, the COPD segment has held the largest market share of 45% in 2022.
- By application, the asthma segment is expected to expand at the fastest CAGR over the projected period.
- By end user, the hospitals and clinics segment generated over 41% of revenue share in 2022.
- By end user, the home healthcare segment is expected to expand at the fastest CAGR over the projected period.
Read More: Screen-printed Electrodes Market Size, Growth, Report 2032
By Type:
The home spirometer market encompasses various types of devices tailored to meet diverse user needs. Traditional handheld spirometers, designed for ease of use and portability, remain a popular choice. Additionally, newer models include desktop spirometers and wearable spirometry devices, providing users with different options based on their preferences and lifestyle.
By Technology:
Technological advancements have significantly influenced the home spirometer market. Smart spirometers, equipped with Bluetooth connectivity and compatible mobile applications, allow for seamless data integration and remote monitoring. These devices leverage cloud technology, ensuring real-time access to lung function data for both users and healthcare professionals. This integration enhances the overall user experience and facilitates proactive healthcare management.
By Application:
Home spirometers serve various applications, catering to a broad spectrum of respiratory health needs. They are commonly used for monitoring chronic respiratory conditions such as asthma and COPD, enabling individuals to track changes in lung function over time. Additionally, home spirometry finds application in postoperative care, respiratory rehabilitation, and as a preventive measure for individuals at risk of respiratory issues.
By End User:
The end user profile of the home spirometer market is diverse, reflecting the broad range of individuals benefiting from these devices. Patients with chronic respiratory conditions form a significant portion of the end users, as home spirometers empower them to actively participate in managing their health. Healthcare providers, including pulmonologists and general practitioners, incorporate home spirometry data into their decision-making processes. Furthermore, the market extends to wellness-conscious individuals and those recovering from respiratory infections, highlighting the versatility of home spirometers across different end-user segments.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Home Spirometer Market Players
- Vitalograph Ltd.
- MIR (Medical International Research)
- Schiller AG
- Nihon Kohden Corporation
- NDD Medical Technologies
- Contec Medical Systems Co., Ltd.
- Microlife Corporation
- Fysiomed
- CareFusion Corporation (acquired by BD)
- SDI Diagnostics
- Cosmed
- Jones Medical Instrument Company
- Bionet America, Inc.
- Futuremed America Inc.
- Medtronic plc
Segments Covered in the Report
By Type
- Hand-Held
- Table-Top
By Technology
- Volume Measurement
- Flow Measurement
By Application
- Asthma
- COPD
- Others
By End User
- Hospitals and Clinics
- Home Healthcare
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Home Spirometer Market
5.1. COVID-19 Landscape: Home Spirometer Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Home Spirometer Market, By Type
8.1. Home Spirometer Market Revenue and Volume Forecast, by Type, 2023-2032
8.1.1. Hand-Held
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Table-Top
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Home Spirometer Market, By Technology
9.1. Home Spirometer Market Revenue and Volume Forecast, by Technology, 2023-2032
9.1.1. Volume Measurement
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Flow Measurement
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Home Spirometer Market, By Application
10.1. Home Spirometer Market Revenue and Volume Forecast, by Application, 2023-2032
10.1.1. Asthma
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. COPD
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Home Spirometer Market, By End User
11.1. Home Spirometer Market Revenue and Volume Forecast, by End User, 2023-2032
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Home Healthcare
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Home Spirometer Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. Vitalograph Ltd.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. MIR (Medical International Research)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Schiller AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Nihon Kohden Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. NDD Medical Technologies
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Contec Medical Systems Co., Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Microlife Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Fysiomed
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. CareFusion Corporation (acquired by BD)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. SDI Diagnostics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/